Cargando…
A 32-year-old man with hypoxemia and bilateral upper-lobe predominant ground-glass infiltrates on chest imaging
Diffuse alveolar hemorrhage (DAH) is a rare, but potentially fatal, complication of antiphospholipid syndrome, and may present with acute and fulminant symptoms. We report a case of DAH presenting as sudden onset dyspnea in a gentleman with known antiphospholipid syndrome. Chest computed tomography...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6169198/ https://www.ncbi.nlm.nih.gov/pubmed/30302263 http://dx.doi.org/10.1093/omcr/omy072 |
_version_ | 1783360474438434816 |
---|---|
author | Helgeson, Scott A Heckman, Alexander J McCain, Josiah D Cowart, Jennifer B Maniaci, Michael J Garland, Jeffrey L |
author_facet | Helgeson, Scott A Heckman, Alexander J McCain, Josiah D Cowart, Jennifer B Maniaci, Michael J Garland, Jeffrey L |
author_sort | Helgeson, Scott A |
collection | PubMed |
description | Diffuse alveolar hemorrhage (DAH) is a rare, but potentially fatal, complication of antiphospholipid syndrome, and may present with acute and fulminant symptoms. We report a case of DAH presenting as sudden onset dyspnea in a gentleman with known antiphospholipid syndrome. Chest computed tomography angiography with pulmonary embolism protocol showed right lower lobe segmental filling defects, upper-lobe predominant diffuse ground-glass opacities, and centrilobular nodules bilaterally. The presence of DAH can be confirmed by bronchoalveolar lavage with serial aliquots, but this procedure typically does not elucidate the specific etiology for the hemorrhage. The treatment for patients with severe disease typically consists of a combination of immunosuppressive medications in the form of high-dose intravenous glucocorticoids plus rituximab, cyclophosphamide or mycophenolate; and/or plasma exchange. This case both provides an example of high-quality diagnostic imaging of diffuse alveolar hemorrhage as well as demonstrates the clinical and image-based improvement after treatment. |
format | Online Article Text |
id | pubmed-6169198 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-61691982018-10-09 A 32-year-old man with hypoxemia and bilateral upper-lobe predominant ground-glass infiltrates on chest imaging Helgeson, Scott A Heckman, Alexander J McCain, Josiah D Cowart, Jennifer B Maniaci, Michael J Garland, Jeffrey L Oxf Med Case Reports Case Report Diffuse alveolar hemorrhage (DAH) is a rare, but potentially fatal, complication of antiphospholipid syndrome, and may present with acute and fulminant symptoms. We report a case of DAH presenting as sudden onset dyspnea in a gentleman with known antiphospholipid syndrome. Chest computed tomography angiography with pulmonary embolism protocol showed right lower lobe segmental filling defects, upper-lobe predominant diffuse ground-glass opacities, and centrilobular nodules bilaterally. The presence of DAH can be confirmed by bronchoalveolar lavage with serial aliquots, but this procedure typically does not elucidate the specific etiology for the hemorrhage. The treatment for patients with severe disease typically consists of a combination of immunosuppressive medications in the form of high-dose intravenous glucocorticoids plus rituximab, cyclophosphamide or mycophenolate; and/or plasma exchange. This case both provides an example of high-quality diagnostic imaging of diffuse alveolar hemorrhage as well as demonstrates the clinical and image-based improvement after treatment. Oxford University Press 2018-10-03 /pmc/articles/PMC6169198/ /pubmed/30302263 http://dx.doi.org/10.1093/omcr/omy072 Text en © The Author(s) 2018. Published by Oxford University Press. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Case Report Helgeson, Scott A Heckman, Alexander J McCain, Josiah D Cowart, Jennifer B Maniaci, Michael J Garland, Jeffrey L A 32-year-old man with hypoxemia and bilateral upper-lobe predominant ground-glass infiltrates on chest imaging |
title | A 32-year-old man with hypoxemia and bilateral upper-lobe predominant ground-glass infiltrates on chest imaging |
title_full | A 32-year-old man with hypoxemia and bilateral upper-lobe predominant ground-glass infiltrates on chest imaging |
title_fullStr | A 32-year-old man with hypoxemia and bilateral upper-lobe predominant ground-glass infiltrates on chest imaging |
title_full_unstemmed | A 32-year-old man with hypoxemia and bilateral upper-lobe predominant ground-glass infiltrates on chest imaging |
title_short | A 32-year-old man with hypoxemia and bilateral upper-lobe predominant ground-glass infiltrates on chest imaging |
title_sort | 32-year-old man with hypoxemia and bilateral upper-lobe predominant ground-glass infiltrates on chest imaging |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6169198/ https://www.ncbi.nlm.nih.gov/pubmed/30302263 http://dx.doi.org/10.1093/omcr/omy072 |
work_keys_str_mv | AT helgesonscotta a32yearoldmanwithhypoxemiaandbilateralupperlobepredominantgroundglassinfiltratesonchestimaging AT heckmanalexanderj a32yearoldmanwithhypoxemiaandbilateralupperlobepredominantgroundglassinfiltratesonchestimaging AT mccainjosiahd a32yearoldmanwithhypoxemiaandbilateralupperlobepredominantgroundglassinfiltratesonchestimaging AT cowartjenniferb a32yearoldmanwithhypoxemiaandbilateralupperlobepredominantgroundglassinfiltratesonchestimaging AT maniacimichaelj a32yearoldmanwithhypoxemiaandbilateralupperlobepredominantgroundglassinfiltratesonchestimaging AT garlandjeffreyl a32yearoldmanwithhypoxemiaandbilateralupperlobepredominantgroundglassinfiltratesonchestimaging AT helgesonscotta 32yearoldmanwithhypoxemiaandbilateralupperlobepredominantgroundglassinfiltratesonchestimaging AT heckmanalexanderj 32yearoldmanwithhypoxemiaandbilateralupperlobepredominantgroundglassinfiltratesonchestimaging AT mccainjosiahd 32yearoldmanwithhypoxemiaandbilateralupperlobepredominantgroundglassinfiltratesonchestimaging AT cowartjenniferb 32yearoldmanwithhypoxemiaandbilateralupperlobepredominantgroundglassinfiltratesonchestimaging AT maniacimichaelj 32yearoldmanwithhypoxemiaandbilateralupperlobepredominantgroundglassinfiltratesonchestimaging AT garlandjeffreyl 32yearoldmanwithhypoxemiaandbilateralupperlobepredominantgroundglassinfiltratesonchestimaging |